CVS Health Co. (NYSE:CVS) Director Buys $100,009.00 in Stock

CVS Health Co. (NYSE:CVS) Director Guy P. Sansone acquired 1,570 shares of the firm’s stock in a transaction that occurred on Thursday, June 5th. The shares were purchased at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the acquisition, the director now owns 12,007 shares in the company, valued at $764,845.90. This represents a 15.04% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

CVS Health Trading Up 0.5%

CVS opened at $64.21 on Wednesday. The stock has a market cap of $81.22 billion, a PE ratio of 17.54, a PEG ratio of 0.98 and a beta of 0.56. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The business has a 50 day moving average of $65.06 and a 200-day moving average of $60.01. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $72.51.

CVS Health (NYSE:CVS) last released its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.63. The company had revenue of $94.59 billion during the quarter, compared to analysts’ expectations of $93.07 billion. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.31 EPS. Equities research analysts predict that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.14%. The ex-dividend date of this dividend was Tuesday, April 22nd. CVS Health’s payout ratio is 63.48%.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on CVS. Barclays set a $79.00 price objective on CVS Health and gave the company an “overweight” rating in a report on Monday, June 2nd. Royal Bank of Canada raised their price target on CVS Health from $74.00 to $81.00 and gave the stock an “outperform” rating in a research report on Monday, May 5th. Wolfe Research raised their price target on CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 11th. JPMorgan Chase & Co. raised their price target on CVS Health from $80.00 to $81.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 18th. Finally, Mizuho raised their price target on CVS Health from $70.00 to $76.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 9th. Two equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $74.75.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Bell Investment Advisors Inc raised its stake in CVS Health by 119.8% during the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares during the last quarter. Saudi Central Bank purchased a new position in CVS Health during the first quarter valued at $34,000. Costello Asset Management INC raised its stake in CVS Health by 281.3% during the first quarter. Costello Asset Management INC now owns 572 shares of the pharmacy operator’s stock valued at $39,000 after buying an additional 422 shares during the last quarter. Stone House Investment Management LLC purchased a new position in CVS Health during the first quarter valued at $39,000. Finally, Stonebridge Financial Group LLC purchased a new position in CVS Health during the fourth quarter valued at $28,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.